CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.90 +0.06 (+6.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Market Capitalization (2023 - 2026)

Updated

CytoMed Therapeutics' Market Capitalization came in at $15.85 million for Q4 2025, down 59.6% from $39.24 million a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Market Capitalization (2023 - 2026) Analysis & Trends

Going back to Q2 2023, CytoMed Therapeutics' Market Capitalization data covers 6 quarters.

  • Going back by year, Market Capitalization was $39.24 million in FY2024 (-30.6%) and $56.55 million in FY2023.
  • Year-over-year, Market Capitalization increased in 1 of the last four quarters, with an average decline of 20.7%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 CytoMed Therapeutics 9.94 Mn -1.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.18 Mn
Dec 31, 2025 15.85 Mn
Jun 30, 2025 25.97 Mn
Dec 31, 2024 39.24 Mn
Jun 30, 2024 24.00 Mn
Dec 31, 2023 56.55 Mn
Jun 30, 2023 24.14 Mn
API Access

CytoMed Therapeutics Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=GDTC&period=max&api_key=YOUR_API_KEY